The Secretariat of the Global Framework on Chemicals, adopted in September 2023 at the Fifth International Conference on Chemicals Management (ICCM5), is pleased to announce that the First ...

Low-code platforms now power enterprise applications at the speed and agility that traditional development cannot match. Yet adoption in healthcare, finance and government is cautious—not for lack of ...

Abstract: Cross-view geo-localization (CVGL) task aims to match images of the same object captured from various platforms, such as drones and satellites. The primary challenge of CVGL is that the ...

Abstract: Code vulnerability detection (CVD) is a critical approach to ensuring the security, stability, and reliability of software. When exploited by malicious actors or hackers, code ...

The mandating resolution encourages international organizations, civil society, and other relevant stakeholders to contribute to the work of the intergovernmental negotiating committee in accordance ...

Django, Flask, RDBMS, PostgreSQL, MySQL, HTML5, HTML, CSS, Javascript, jQuery, Angular, Linux, Docker, Kubernetes, Jenkins, AWS, Azure, GCP,Scrapy, ReactJS, CICD, GIT ...

Microsoft is warning of an insecure practice wherein software developers are incorporating publicly disclosed ASP.NET machine keys from publicly accessible resources, thereby putting their ...

Microsoft warns that attackers are deploying malware in ViewState code injection attacks using static ASP. NET machine keys found online. As Microsoft Threat Intelligence experts recently discovered, ...

In December 2024, Microsoft Threat Intelligence observed limited activity by an unattributed threat actor using a publicly available, static ASP.NET machine key to inject malicious code and deliver ...

Molly Qerim has already created an incredible career legacy. The Connecticut-born sports broadcaster began her career at the University of Connecticut, where she obtained a B.F.A. in Communications.

Astellas Pharma Inc. presented the first preclinical data on ASP-1002, a bispecific antibody targeting claudin-4 (CLDN4) and CD137, for the treatment of patients with metastatic or locally advanced ...